|
![]() |
Please check the full coverage of information what EMIS can offer you. | SEE SAMPLE |
Company Information |
|
Full name Ajanta Pharma Ltd. Legal Address Ajanta House, Charkop, Kandivali (W); Mumbai; Maharashtra; 400067 |
Status: Listed Legal Form: Public Limited Company Operational Status: Operational ISIN CODE : INE031B01015 Financial Auditors: Kapoor & Parekh Associates (2011) Incorporation Date: August 11, 1986 Total Employees: 1,300 Tel: 91-22-66061000 |
|
Company Description |
|
The company was incorporated in 1979, it belongs to the Ajanta Pharma Group. It is in the business of pharmaceuticals as well as ayurvedic preparations. It manufactures capsules, injectable, liquids, powder, tablets at Aurangabad in Maharashtra. S |
Company Analysis |
| According to the Consolidated - Audited financial statement for the Year of 2012, total net operating revenues increased with 34.65%, from INR 507.7 tens of millions to INR 683.62 tens of millions. Operating result increased from INR 96.31 tens of millions to INR 146.96 tens of millions which means 52.59% change. The results of the period increased 52.35% reaching INR 77.27 tens of millions at the end of the period against INR 50.72 tens of millions last year. Return on equity (Net income/Total equity) went from 22.16% to 25.93%, the Return On Asset (Net income / Total Asset) went from 11.78% to 19.38% and the Net Profit Margin (Net Income/Net Sales) went from 9.99% to 11.30% when compared to the same period of last year. The Debt to Equity Ratio (Total Liabilities/Equity) was 25.53% compared to 188.08% of last year. Finally, the Current Ratio (Current Assets/Current Liabilities) went from 3.08 to 1.36 when compared to the previous year. |
Key Executives |
|
|||||
|
|||||
|
|||||
|
|||||
|
|||||
|
|||||
Companies with Similar Main Activities |

|
|
2013 Y (cons) |
2013 Q3C (non-cons) |
|
![]() | ||
| Non-Audited | Non-Audited | |
![]() | ||
| Dion Global Solutions - AsianCERC | Dion Global Solutions - AsianCERC | |
![]() | ||
| Unit | Tens of Millions) | Tens of Millions |
![]() | ||
![]() | ||
Shareholders Equity |
393 |
11 |
![]() | ||
| * All the accounts are in INR. | ||
![]() | ||
Total Operating Revenue |
930 |
589 |
![]() | ||
Operational Profit (Loss) |
115 |
|
![]() | ||
Net Profit (Loss) |
112 |
74 |
![]() | ||
| * All the accounts are in INR. | ||
| Profitability Ratios | ||
![]() | ||
Return on Equity (ROE) |
950.08% |
627.37% |
![]() | ||
Annualised Return on Equity (ROE) |
950.08% |
836.49% |
![]() | ||
Return on Sales (ROS) |
101.16% |
101.81% |
![]() | ||